Regulating AI-Based Medical Devices in Saudi Arabia: New Legal Paradigms in an Evolving Global Legal Order
Asian Bioethics Review · 2024-07 · 16 (3) · 373-389
DOI: 10.1007/s41649-024-00285-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Bioethics Review, online erschienen am 21.06.2024. Verfasst von Barry Solaiman. Beteiligte Einrichtung: College of Law, Hamad Bin Khalifa University, Doha, Qatar. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hamad bin Khalifa University.
Abstract (Originalsprache)
This paper examines the Saudi Food and Drug Authority’s (SFDA) Guidance on Artificial Intelligence (AI) and Machine Learning (ML) technologies based Medical Devices (the MDS-G010). The SFDA has pioneered binding requirements designed for manufacturers to obtain Medical Device Marketing Authorization. The regulation of AI in health is at an early stage worldwide. Therefore, it is critical to examine the scope and nature of the MDS-G010, its influences, and its future directions. It is argued that the guidance is a patchwork of existing international best practices concerning AI regulation, incorporates adapted forms of non-AI-based guidelines, and builds on existing legal requirements in the SFDA’s existing regulatory architecture. There is particular congruence with the approaches of the US Food and Drug Administration (FDA) and the International Medical Device Regulators Forum (IMDRF), but the SFDA goes beyond those approaches to incorporate other best practices into its guidance. Additionally, the binding nature of the MDS-G010 is complex. There are binding ‘components’ within the guidance, but the incorporation of non-binding international best practices which are subordinate to national law results in a lack of clarity about how penalties for non-compliance will operate.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Law, Hamad Bin Khalifa University, Doha, Qatar.
ORCID-Profile: Barry Solaiman
Förderung
- Hamad bin Khalifa University
Zitieren
APA
Solaiman, B. (2024). Regulating AI-Based Medical Devices in Saudi Arabia: New Legal Paradigms in an Evolving Global Legal Order. Asian Bioethics Review, 16(3), 373-389. https://doi.org/10.1007/s41649-024-00285-6
Vancouver
Solaiman B. Regulating AI-Based Medical Devices in Saudi Arabia: New Legal Paradigms in an Evolving Global Legal Order. Asian Bioethics Review. 2024;16(3):373-389. doi:10.1007/s41649-024-00285-6
BibTeX
@article{Solaiman2024,
author = {Solaiman, Barry},
title = {Regulating AI-Based Medical Devices in Saudi Arabia: New Legal Paradigms in an Evolving Global Legal Order},
journal = {Asian Bioethics Review},
year = {2024},
volume = {16},
number = {3},
pages = {373--389},
doi = {10.1007/s41649-024-00285-6}
}
EUVIMED